We are excited to be attending the National Association of Medicaid Directors (NAMD) Fall Conference this week. If you’re attending, you can connect with us at booth 75!

Find your place at Prime! Join our team and help reimagine pharmacy solutions to provide the care you would want for your loved ones. Learn more about current job opportunities here: bit.ly/3Z3qYLV

Today is #WorldDiabetesDay. This year’s campaign encourages people to share their experiences and advocate for better care practices that address the physical, mental and emotional aspects of living with diabetes. Learn more: bit.ly/2oh9jlu

The Prime Together Foundation gives to Bear Hug Cattle Company, whose mission is to provide hands-on training to veterans pursuing a career in the ranching industry. Learn more about how we’re supporting Bear Hug Cattle Company here: bit.ly/3AHWaHg

Take advantage of this quarter's clinical insights and competitive intelligence to stay ahead of the ever-evolving market. Access the quarterly drug pipeline here: bit.ly/3OaxtXa

Our newest High-Cost Therapy Profile has arrived. Dive deeper with our experts: bit.ly/40haKzE

Take a closer look at our snapshot of new drugs expected to hit the market in November here: bit.ly/4hcR5XX

At Prime, we’re focused on putting more care in health care. That starts with the people who work on our front lines. Watch recruiter Tracy Meichsner share why Prime is a great place to work if you want to make a difference: bit.ly/4eDfjYS

Maryam Tabatabai and Prime’s government affairs experts Caitlin Berry and Julie Cantor-Weinberg sat down for a timely discussion about the election. Listen in for insights on how the election may impact health care and pharmacy benefit management here: bit.ly/4ffsuQk

Can you tell if a glucagon-like peptide-1 (GLP-1) drug is fake? Jessica Johnson, clinical consultant at Prime’s Special Investigations Unit, shares how to identify and avoid counterfeit GLP-1s. Read more: bit.ly/3Zck07y

Hear from Simone Ndujiuba, PharmD, BCOP as she discusses the difference between oncology case management and navigation in the latest Oncology Insights. Learn more: bit.ly/4hXMs4q

Our newest High-Cost Therapy Profile has arrived! Dive deeper with our experts here: bit.ly/4hWXEy9

Many promising new oncology drugs are making their way through the FDA accelerated approval process. Learn more about recent withdrawn and traditional approvals and those awaiting accelerated approval in the Fall 2024 Prime Therapeutics Report: bit.ly/3CyKozo

Join us in welcoming George Van Antwerp as he helps Prime build the future of innovative pharmacy solutions that improve affordability and outcomes for our customers and members.

Our tight-knit health care community grieves today as we learn of the tragic news in New York. Our hearts and prayers are with Brian Thompson’s family, friends and colleagues. reuters.com/world/us/unite…

Our latest Drug Approvals update showcases significant advancements in the pharmaceutical landscape and includes new key approvals. Read the full report for detailed insights: bit.ly/43jN0MQ

Our team of clinical experts actively monitors the evolving GLP-1 landscape to deliver better outcomes for our members. Get your GLP-1 questions answered in our latest update: bit.ly/4bo9EWG

Looking for an informative podcast that doesn’t take up three hours of your day? Tune in to ’Pharmacy Friends,’ where industry experts gather to discuss the latest in pharmacy! Listen and subscribe: bit.ly/4ffsuQk

Health care is costly, complex and constantly changing. We're here to help you address the challenges that keep you up at night. Check out our suite of customized, market-leading solutions designed to help you, your clients and your members save: bit.ly/3UFp7ud

New GLP-1 research exclusive! 🚨 Check out this Reuters exclusive on Prime's latest industry-leading analysis on glucagon-like peptide-1 (GLP-1) drug data, based on integrated pharmacy and medical claims info. Keep reading: reut.rs/3HWi4K8